136 related articles for article (PubMed ID: 25763830)
1. Evaluation of the Effect of Cumulative Operator Experience on Hepatocellular Carcinoma Recurrence after Primary Treatment with Radiofrequency Ablation.
Lee TY; Lin JT; Ho HJ; Wu MS; Wu CY
Radiology; 2015 Jul; 276(1):294-301. PubMed ID: 25763830
[TBL] [Abstract][Full Text] [Related]
2. Association between nucleos(t)ide analog and tumor recurrence in hepatitis B virus-related hepatocellular carcinoma after radiofrequency ablation.
Lee TY; Lin JT; Zeng YS; Chen YJ; Wu MS; Wu CY
Hepatology; 2016 May; 63(5):1517-27. PubMed ID: 26426978
[TBL] [Abstract][Full Text] [Related]
3. Predisposing factors for recurrence of HBV-related small hepatocellular carcinoma after percutaneous radiofrequency ablation.
Sohn W; Paik YH; Lee MW; Rhim H; Lim HK; Cho JY; Gwak GY; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC
Scand J Gastroenterol; 2014 Mar; 49(3):373-80. PubMed ID: 24354931
[TBL] [Abstract][Full Text] [Related]
4. Topographical impact of hepatitis B-related hepatocellular carcinoma on local recurrence after radiofrequency ablation.
Kim JS; Kim W; So YH; Yu SJ; Kim BG
J Clin Gastroenterol; 2014 Jan; 48(1):66-72. PubMed ID: 23751848
[TBL] [Abstract][Full Text] [Related]
5. Aggressive Intrasegmental Recurrence of Hepatocellular Carcinoma after Radiofrequency Ablation: Risk Factors and Clinical Significance.
Kang TW; Lim HK; Lee MW; Kim YS; Rhim H; Lee WJ; Gwak GY; Paik YH; Lim HY; Kim MJ
Radiology; 2015 Jul; 276(1):274-85. PubMed ID: 25734550
[TBL] [Abstract][Full Text] [Related]
6. Recurrence-free survival after radiofrequency ablation of hepatocellular carcinoma. A registry report of the impact of risk factors on outcome.
Zytoon AA; Ishii H; Murakami K; El-Kholy MR; Furuse J; El-Dorry A; El-Malah A
Jpn J Clin Oncol; 2007 Sep; 37(9):658-72. PubMed ID: 17766723
[TBL] [Abstract][Full Text] [Related]
7. Radiofrequency ablation for hepatocellular carcinoma measuring 2 cm or smaller: results and risk factors for local recurrence.
Kono M; Inoue T; Kudo M; Chishina H; Arizumi T; Takita M; Kitai S; Yada N; Hagiwara S; Minami Y; Ueshima K; Nishida N; Murakami T
Dig Dis; 2014; 32(6):670-7. PubMed ID: 25376283
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for the recurrence of hepatocellular carcinoma after radiofrequency ablation of hepatocellular carcinoma in patients with hepatitis C.
Yamanaka Y; Shiraki K; Miyashita K; Inoue T; Kawakita T; Yamaguchi Y; Saitou Y; Yamamoto N; Nakano T; Nakatsuka A; Yamakado K; Takeda K
World J Gastroenterol; 2005 Apr; 11(14):2174-8. PubMed ID: 15810088
[TBL] [Abstract][Full Text] [Related]
9. Association between nucleoside analogues and risk of hepatitis B virus–related hepatocellular carcinoma recurrence following liver resection.
Wu CY; Chen YJ; Ho HJ; Hsu YC; Kuo KN; Wu MS; Lin JT
JAMA; 2012 Nov; 308(18):1906-14. PubMed ID: 23162861
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for the local recurrence of hepatocellular carcinoma after a single session of percutaneous radiofrequency ablation.
Hori T; Nagata K; Hasuike S; Onaga M; Motoda M; Moriuchi A; Iwakiri H; Uto H; Kato J; Ido A; Hayashi K; Tsubouchi H
J Gastroenterol; 2003; 38(10):977-81. PubMed ID: 14614605
[TBL] [Abstract][Full Text] [Related]
11. Younger hepatocellular carcinoma patients have better prognosis after percutaneous radiofrequency ablation therapy.
Kao WY; Chiou YY; Hung HH; Su CW; Chou YH; Huo TI; Huang YH; Wu WC; Lin HC; Lee SD; Wu JC
J Clin Gastroenterol; 2012 Jan; 46(1):62-70. PubMed ID: 21934530
[TBL] [Abstract][Full Text] [Related]
12. Recurrence after liver resection for hepatocellular carcinoma: risk factors, treatment, and outcomes.
Shah SA; Cleary SP; Wei AC; Yang I; Taylor BR; Hemming AW; Langer B; Grant DR; Greig PD; Gallinger S
Surgery; 2007 Mar; 141(3):330-9. PubMed ID: 17349844
[TBL] [Abstract][Full Text] [Related]
13. Initial treatment response is essential to improve survival in patients with hepatocellular carcinoma who underwent curative radiofrequency ablation therapy.
Takahashi S; Kudo M; Chung H; Inoue T; Ishikawa E; Kitai S; Tatsumi C; Ueda T; Minami Y; Ueshima K; Haji S
Oncology; 2007; 72 Suppl 1():98-103. PubMed ID: 18087189
[TBL] [Abstract][Full Text] [Related]
14. Percutaneous radiofrequency ablation as first-line treatment for small hepatocellular carcinoma: results and prognostic factors on long-term follow up.
Waki K; Aikata H; Katamura Y; Kawaoka T; Takaki S; Hiramatsu A; Takahashi S; Toyota N; Ito K; Chayama K
J Gastroenterol Hepatol; 2010 Mar; 25(3):597-604. PubMed ID: 20074153
[TBL] [Abstract][Full Text] [Related]
15. Repeated radiofrequency ablation for management of patients with cirrhosis with small hepatocellular carcinomas: a long-term cohort study.
Rossi S; Ravetta V; Rosa L; Ghittoni G; Viera FT; Garbagnati F; Silini EM; Dionigi P; Calliada F; Quaretti P; Tinelli C
Hepatology; 2011 Jan; 53(1):136-47. PubMed ID: 20967759
[TBL] [Abstract][Full Text] [Related]
16. Risk factors of recurrence after curative resection of hepatocellular carcinoma in Taiwan.
Liao KF; Lai SW; Lin CY; Huang CH; Lin YY
Am J Med Sci; 2011 Apr; 341(4):301-4. PubMed ID: 21441859
[TBL] [Abstract][Full Text] [Related]
17. High serum des-gamma-carboxy prothrombin level predicts poor prognosis after radiofrequency ablation of hepatocellular carcinoma.
Kobayashi M; Ikeda K; Kawamura Y; Yatsuji H; Hosaka T; Sezaki H; Akuta N; Suzuki F; Suzuki Y; Saitoh S; Arase Y; Kumada H
Cancer; 2009 Feb; 115(3):571-80. PubMed ID: 19117347
[TBL] [Abstract][Full Text] [Related]
18. Is serum alpha-fetoprotein useful for predicting recurrence and mortality specific to hepatocellular carcinoma after hepatectomy? A test based on propensity scores and competing risks analysis.
Shim JH; Yoon DL; Han S; Lee YJ; Lee SG; Kim KM; Lim YS; Lee HC; Chung YH; Lee YS
Ann Surg Oncol; 2012 Nov; 19(12):3687-96. PubMed ID: 22644512
[TBL] [Abstract][Full Text] [Related]
19. Negative hepatitis B envelope antigen predicts intrahepatic recurrence in hepatitis B virus-related hepatocellular carcinoma after ablation therapy.
Chung GE; Kim W; Lee JH; Kim YJ; Yoon JH; Lee JM; Lee JY; Kim SH; Kim D; Lee HS
J Gastroenterol Hepatol; 2011 Nov; 26(11):1638-45. PubMed ID: 22011297
[TBL] [Abstract][Full Text] [Related]
20. Association of nucleos(t)ide analogue therapy with reduced risk of hepatocellular carcinoma in patients with chronic hepatitis B: a nationwide cohort study.
Wu CY; Lin JT; Ho HJ; Su CW; Lee TY; Wang SY; Wu C; Wu JC
Gastroenterology; 2014 Jul; 147(1):143-151.e5. PubMed ID: 24704525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
